$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What are the common adverse reactions of Imatinib (Gleevec) and how to deal with them
2026-02-01 22:25:32
Check Details
Ruxolitinib cream (Opzelura) side effects treatment methods and medication safety guidance
2026-02-01 22:25:32
Check Details
Analysis of the actual efficacy and patient feedback of Epclusa in the treatment of hepatitis C
2026-02-01 22:25:32
Check Details
Analysis of clinical efficacy and real patient feedback of Sunitinib (Sutent)
2026-02-01 22:25:32
Check Details
What are the alternative drugs to Tazetostat (Davico) and comparative analysis of their efficacy
2026-02-01 22:25:32
Check Details
Ceritinib/Ceritinib (Zanda) side effects treatment methods and daily safety suggestions
2026-02-01 22:25:32
Check Details
Can Bestivan (Vilire) be taken for a long time and what are the recommendations for the duration of treatment?
2026-02-01 22:25:32
Check Details
Dabrafenib (Tefila) single dose duration of efficacy and clinical reference
2026-02-01 22:25:32
Check Details
Comprehensive interpretation and evaluation of the efficacy, effects and potential side effects of axitinib (Inlida)
2026-02-01 22:25:32
Check Details
How long does it take for Trametinib (Megenin) to take effect and reference for efficacy evaluation
2026-02-01 22:25:32
Check Details
Pregnancy risks and precautions while taking avatrombopag (Sucoxin)
2026-02-01 22:25:32
Check Details
What are the common side effects of Giritinib (Segatan) and relief measures?
2026-02-01 22:25:32
Check Details
1
2
...
2096
2097
2098
2099
2100
2101
2102
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
2
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
3
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
4
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
5
Pretomanid for Drug-Resistant TB: Risks and Management of 3-Year Treatment
6
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
7
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
8
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
9
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
10
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
11
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
12
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment